Investing.com - Morphosys AG reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Morphosys AG announced earnings per share of €6.11 on revenue of €251.2M. Analysts polled by Investing.com anticipated EPS of €3.16 on revenue of €174.5M. That with comparison to EPS of €-0.72 on revenue of €13.5M in the same period a year before.Morphosys AG had reported EPS of €-1.59 on revenue of €11.1M in the previous quarter.Analysts are expecting EPS of €-0.66 and revenue of €37.22M in the upcoming quarter.
Morphosys AG shares are down 29% from the beginning of the year and are trading at €102.025 , down-from-52-week-high.They are under-performing the STOXX 600 which is down 19.73% year to date.
Morphosys AG follows other major Healthcare sector earnings this month
Morphosys AG's report follows an earnings beat by Bayer on Monday, April 27, 2020, who reported EPS of €2.67 on revenue of €12.85B, compared to forecasts EPS of €2.52 on revenue of €12.57B.
Siemens Healthineers had beat expectations on Tuesday with second quarter EPS of €0.43 on revenue of €3.69B, compared to forecast for EPS of €0.4 on revenue of €3.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar